Stockscreener 앱 받기
2.68
5.93%
0.15
시간 외 거래:
2.70
0.02
+0.75%
전일 마감가:
$2.53
열려 있는:
$2.54
하루 거래량:
10.76M
Relative Volume:
2.28
시가총액:
$540.35M
수익:
$116.33M
순이익/손실:
$-209.25M
주가수익비율:
-1.2642
EPS:
-2.12
순현금흐름:
$-135.49M
1주 성능:
+20.72%
1개월 성능:
+65.43%
6개월 성능:
+62.42%
1년 성능:
+55.81%
1일 변동 폭
$2.535
$2.71
1주일 범위
$2.20
$2.71
52주 변동 폭
$0.6925
$3.94
Esperion Therapeutics Inc Stock (ESPR) Company Profile
명칭
Esperion Therapeutics Inc
전화
734-887-3903
주소
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
ESPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESPR
Esperion Therapeutics Inc
|
2.68 | 510.11M | 116.33M | -209.25M | -135.49M | -2.12 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Goldman | Neutral |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-20 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-08-01 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2023-06-15 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2023-03-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-03-16 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2023-03-07 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2023-02-27 | 재개 | BofA Securities | Neutral |
| 2023-02-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-02-03 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-08-03 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2022-05-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-03-10 | 개시 | H.C. Wainwright | Buy |
| 2021-10-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2021-10-14 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-05-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-03-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-01-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-09-29 | 재개 | JP Morgan | Underweight |
| 2020-08-11 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2020-04-01 | 재개 | BofA/Merrill | Buy |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-24 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2020-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-09-16 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-05-29 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-05-06 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-04-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-03-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-07 | 재확인 | Needham | Strong Buy |
| 2018-12-13 | 개시 | Goldman | Sell |
| 2018-10-29 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2018-10-16 | 개시 | BTIG Research | Buy |
| 2018-08-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-07-11 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2018-05-03 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-05-02 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
모두보기
Esperion Therapeutics Inc 주식(ESPR)의 최신 뉴스
Candlestick signals on Esperion Therapeutics Inc. stock todayJuly 2025 Review & Comprehensive Market Scan Reports - Newser
How sensitive is Esperion Therapeutics Inc. to inflationJuly 2025 Gainers & Free Community Consensus Stock Picks - خودرو بانک
Market reaction to Esperion Therapeutics Inc.’s recent news2025 Earnings Impact & Short-Term High Return Ideas - Newser
How does Esperion Therapeutics Inc. perform in inflationary periodsJuly 2025 Chart Watch & Safe Entry Point Alerts - خودرو بانک
Will Esperion Therapeutics Inc. stock recover after recent drop2025 Pullback Review & Weekly Market Pulse Alerts - Newser
Combining machine learning predictions for Esperion Therapeutics Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Is Esperion Therapeutics Inc. forming a bullish divergenceJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - خودرو بانک
Esperion Therapeutics Inc. stock chart pattern explained2025 Fundamental Recap & High Accuracy Investment Signals - Newser
Reversal indicators forming on Esperion Therapeutics Inc. stockPortfolio Performance Report & Fast Entry High Yield Tips - Newser
Top 2 Health Care Stocks That May Plunge This Month - Benzinga
Is Esperion Therapeutics Inc. still a buy after recent gainsJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - خودرو بانک
Is this a good reentry point in Esperion Therapeutics Inc.Earnings Recap Report & Long-Term Safe Investment Plans - Newser
Published on: 2025-09-05 06:44:23 - Newser
Esperion Therapeutics shares rise 2.77% premarket after presenting at Cantor. - AInvest
Esperion Therapeutics’ Path to Profitability and Global Expansion in the Cardiovascular Space - AInvest
Best data tools to analyze Esperion Therapeutics Inc. stockMarket Movement Recap & Risk Controlled Swing Trade Alerts - Newser
Analyzing recovery setups for Esperion Therapeutics Inc. investorsJuly 2025 Gainers & Precise Buy Zone Identification - Newser
What the charts say about Esperion Therapeutics Inc. todayBuy Signal & Safe Capital Preservation Plans - Newser
Signal strength of Esperion Therapeutics Inc. stock in tech scannersWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
Why Did Esperion Therapeutics Inc (ESPR) Soar 15.23% on Positive Q2 Earnings? - AInvest
Using flow based indicators on Esperion Therapeutics Inc.July 2025 PreEarnings & Precise Buy Zone Identification - Newser
What institutional flow reveals about Esperion Therapeutics Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser
Will Esperion Therapeutics Inc. benefit from macro trendsQuarterly Earnings Summary & Reliable Intraday Trade Alerts - Newser
Can Esperion Therapeutics Inc. scale operations efficientlyJuly 2025 Action & Fast Gaining Stock Reports - خودرو بانک
Developing predictive dashboards with Esperion Therapeutics Inc. data2025 Performance Recap & AI Driven Stock Reports - Newser
Should you hold or exit Esperion Therapeutics Inc. nowJuly 2025 Movers & AI Optimized Trade Strategies - Newser
Real time pattern detection on Esperion Therapeutics Inc. stockPortfolio Value Summary & Growth Focused Stock Pick Reports - Newser
Tools to monitor Esperion Therapeutics Inc. recovery probabilityJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - Newser
Technical analysis overview for Esperion Therapeutics Inc. stockWeekly Trade Summary & Weekly High Return Forecasts - Newser
Is Esperion Therapeutics Inc. benefiting from innovation trendsQuarterly Profit Review & AI Powered Buy/Sell Recommendations - khodrobank.com
Using Bollinger Bands to evaluate Esperion Therapeutics Inc.Quarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Detecting support and resistance levels for Esperion Therapeutics Inc.Market Performance Recap & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-02 13:26:49 - Newser
Is Esperion Therapeutics Inc. stock ready for a breakout2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Can Esperion Therapeutics Inc. keep up with sector leadersOil Prices & Weekly Setup with High ROI Potential - خودرو بانک
Movement Recap: Can Esperion Therapeutics Inc. scale operations efficientlyGap Down & Real-Time Chart Pattern Alerts - خودرو بانک
Esperion rises after revenue beat, Q1 profitability expectation - MSN
Using data tools to time your Esperion Therapeutics Inc. exit2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Published on: 2025-09-01 19:45:56 - Newser
Analyzing Esperion Therapeutics Inc. with risk reward ratio chartsProduct Launch & Fast Entry Momentum Alerts - Newser
Esperion Therapeutics Inc (ESPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Esperion Therapeutics Inc 주식 (ESPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Halladay Benjamin | Chief Financial Officer |
Jul 17 '25 |
Sale |
1.11 |
11 |
12 |
474,462 |
3.53%
자본화:
|
볼륨(24시간):